SARS-CoV-2 Spike RBD (395-430)

This 36-residue peptide spans SARS-CoV-2 spike RBD residues 395-430. It provides a defined receptor-binding-domain segment for antibody-binding, epitope-mapping and spike interaction studies.

• viral immunology and T-cell research
• epitope mapping and antigen presentation
• cell-penetrating peptide studies
• host-pathogen interaction research

Exact residue boundaries, fluorescent labels, species origin and HLA/MHC context are integral to reagent identity. These products are intended for research use and should be matched to the specific assay design.

1. Selected publication/search record